Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

Published 2012 View Full Article

Authors

Keywords

Journal

AMERICAN HEART JOURNAL

Volume 164, Issue 6, Pages e19

Publisher

Elsevier BV

Online

2012-10-29

DOI

10.1016/j.ahj.2012.09.012

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

AMERICAN HEART JOURNAL

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Add your recorded webinar